Request that the FDA determine whether Rectiv® (nitroglycerin) Ointment 0.4%; NDA 021359 of ABBVIE INC has been voluntarily withdrawn from sale
🏛 Food and Drug Administration (FDA)FDA-2026-P-4566
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
NoticeJun 26, 2026
Determination That RECTIV (Nitroglycerin) Ointment, 0.4%, Was Not Withdrawn From Sale for Reasons of Safety or EffectivenessNo comment period
- Other· Jun 26, 2026No comment period
- Other· Apr 24, 2026No comment period